The fact of biotech investing is that the share prices are at the mercy of news flow from drug trial results, partnerships with bigger companies, regulatory interactions and a wide range of other even..

In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, says that based on its attractive valuation, there may be further upside in Altium (ALU) shares over the near term..

The year has started with a rush with the stock market adding over 6% in January. Our model portfolios have also enjoyed solid gains.

For our “HOT” stock, Raymond Chan, Head of Asian Desk at Morgans explains why he says to add PEXA Group (PXA) to your portfolio.

There’s no shortage of world-class innovation coming out of our neighbour across the ditch. Here are three Kiwi stocks that I think are global standouts in their fields — and each of these, for va..

In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, says Karoon Energy (KAR)

For “risk taking” income seekers, investing in a royalty company may have appeal, when the yield is over 6%.

For our “HOT” stock today, Michael Gable, managing director of Fairmont Equities, gives his reasons for liking Iluka Resources (ILU).

These two beaten-up small-cap industrials offer opportunity as markets improve.

Here are three of the best (non-Kiwi) foreign listings: Block (Afterpay), Resmed and Zimplats.